MANDY BLACK: Open Payments
NPI 1386049385 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,729 in 77 payments from 20 companies in 2025. Trend: 2023 $1,851 · 2024 $2,438 · 2025 $1,729
Food & beverage: $1,729
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $216 |
| Lilly USA, LLC | 10 | $208 |
| Insulet Corporation | 9 | $197 |
| Sequel Med Tech, LLC | 2 | $192 |
| Xeris Pharmaceuticals, Inc. | 6 | $116 |
| Novo Nordisk Inc | 5 | $112 |
| Radius Health, Inc. | 5 | $105 |
| Abbott Laboratories | 4 | $79 |
| Ascendis Pharma Endocrinology Inc | 3 | $72 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $68 |
Products named: Omnipod, TWIIST, JARDIANCE, TEPEZZA, Tymlos, EVENITY, MOUNJARO, Wegovy.
Industry payments across NY — which companies pay providers there.
